Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality …

A Rossi, E Zanardi, V Poletti… - International Journal of …, 2015 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is the result of persistent and progressive
pathologic abnormalities in the small airways, most often associated with alveolar loss …

lnc-IL7R Expression Reflects Physiological Pulmonary Function and Its Aberration Is a Putative Indicator of COPD

OA Bamodu, SM Wu, PH Feng, WL Sun, CW Lin… - Biomedicines, 2022 - mdpi.com
Despite rapidly evolving pathobiological mechanistic demystification, coupled with
advances in diagnostic and therapeutic modalities, chronic obstructive pulmonary disease …

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET cohort–determinants and Consequences

JI Lutter, RA Jörres, FC Trudzinski, P Alter… - … Journal of Chronic …, 2021 - Taylor & Francis
Background In COPD patients of GOLD groups A and B, a high degree of treatment with
inhaled corticosteroids (ICS) has been reported, which is regarded as overtreatment …

[HTML][HTML] Стратегии профилактики обострений хронической обструктивной болезни легких

СН Авдеев - Доктор. ру, 2017 - cyberleninka.ru
Цель обзора: рассмотреть этиологию, клинические последствия, средства
профилактики и лечения обострений хронической обструктивной болезни легких …

Withdrawal of inhaled corticosteroids in patients with COPD–a prospective observational study

AO Nielsen, O Hilberg, JUS Jensen… - … Journal of Chronic …, 2021 - Taylor & Francis
Background Inhaled corticosteroids (ICS) are widely used in the treatment of chronic
obstructive pulmonary disease (COPD), but recent studies have raised doubts whether all …

Optimizing treatment of elderly COPD patients: what role for inhaled corticosteroids?

AP Rossi, E Zanardi, M Zamboni, A Rossi - Drugs & aging, 2015 - Springer
The most recent international documents on the management and therapy of chronic
obstructive pulmonary disease (COPD) recommend inhaled corticosteroids (ICS) in addition …

[HTML][HTML] Drugs for chronic obstructive pulmonary disease

C Jenkins - Australian prescriber, 2017 - ncbi.nlm.nih.gov
Drugs for chronic obstructive pulmonary disease - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

[PDF][PDF] Отмена ингаляционных глюкокортикостероидов у пациентов с хронической обструктивной болезнью легких

СН Авдеев, ЗР Айсанов, ВВ Архипов, АС Белевский… - Scopus, 2019 - elib.usma.ru
Резюме Роль ингаляционных глюкокортикостероидов (иГКС) в терапии пациентов с
хронической обструктивной болезнью легких (ХОБЛ) в современных клинических …

Перспективы фармакотерапии хронической обструктивной болезни легких: возможности комбинированных бронходилататоров и место ингаляционных …

СН Авдеев, ЗР Айсанов, АС Белевский… - …, 2016 - journal.pulmonology.ru
Аннотация Наиболее важными симптомами при хронической обструктивной болезни
легких (ХОБЛ) являются одышка, кашель и продукция мокроты. По данным различных …

Inhaled corticosteroids and pneumonia mortality in COPD patients

P Almagro, P Martinez-Camblor… - European Respiratory …, 2019 - Eur Respiratory Soc
In a recent article, Suissa [1] proposes several alternative hypotheses to explain the
paradoxical effect of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …